Trial Profile
Phase III trial investigating intetumumab in melanoma.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 18 Oct 2011
Price :
$35
*
At a glance
- Drugs Intetumumab (Primary)
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- 18 Oct 2011 New trial record